Codiak Biosciences Company
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.
Technology:
Atrificial Vectors and Immune Cells
Industry:
Atrificial Vectors and Immune Cells
Headquarters:
San Francisco, California, United States
Founded Date:
2015-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
13
Total Funding:
5348629
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-07-05
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership